Compliance 21-cfr-11 Validation Summary Report At ShareVault development, security and operations are seamlessly integrated, such that security is built into the design and 21 CFR 11 compliance validation is part of our standard quality process. Report Whitepapers validation
Datasheets Validation Package 21 cfr 11 Our 21 CFR part 11 Compliance Validation Package contains all the information, test scripts and instructions customers need to conduct their own risk assessment of our software to verify it poses no risk to patients, product quality or data integrity. Whitepapers validation
Earnouts v2 Know when to use Earnouts to reduce risk, break a negotiation deadlock and get it done. Negotiation Whitepapers methodology
Capital Raising Term Sheet Get the strategies and insights to create a realistic term sheet that everyone can agree to. Fundraising Negotiation Webinars
Negotiating Working Capital Working capital can be difficult to understand and is one of the most conflicting issues in M&A negotiations and valuation. Mergers & Acquisitions Negotiation Webinars
Valuation of Your Early Drug Candidate In this whitepaper, author Linda Pullan reviews the different techniques, key variables, and characteristics of what makes a drug candidate more valuable to a partner. Life Sciences Series Valuation Whitepapers
Getting Ready for a Biopharma Partnering Deal This whitepaper provides actionable advice for Biotech business development leaders on how to get ready for a partnering deal. Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers
M&A Negotiations This whitepaper shares the most common scenarios that arise when you are selling your company, the choices you have when negotiating the terms of the sale, and which choices are your best ones, as supported by academic research are covered. Best Practices & Trends Life Sciences Mergers & Acquisitions Negotiation Whitepapers
The Nuts & Bolts of Due Diligence in Biopharma Partnering This whitepaper focuses on best practices in due diligence with the goal of forming productive biopharma partnerships. Best Practices & Trends BioPharma Due Diligence Licensing & Partnering Life Sciences Series Whitepapers
What's Hot and What's Not in Oncology Licensing in 2020? In this whitepaper, Linda Pullan, PhD of Pullan Consulting and our panel of experts provided insights in oncology and immuno-oncology in 2020. Best Practices & Trends BioPharma Life Sciences Other Topics Series Whitepapers
How to Win at the Partnering Game In this white paper, Linda Pullan provides a review of the rules of the partnering game – whether it’s partnering from preclinical to late clinical development – to provide an understanding of what to expect in moving from introductions to negotiations of a license or acquisition and how to win with a clear strategy. Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers
Earnouts: Structures for Breaking Negotiation Deadlocks This white paper features Senior M&A Executive Javier Enrile of Principal Global Investors. Mr. Enrile provides his extensive expertise to explain how earnout, (also "earn-out") structures work and how it can reduce risk for the buyer, add attractive incentives for the seller, and serve to break negotiation deadlocks and get deals consummated. Finance Mergers & Acquisitions Negotiation Whitepapers